Report Description

India telmisartan market is forecasted to grow at a steady pace during the forecast period. The India telmisartan market is driven by surging population with cardiovascular and heart associated disorders in India. Additionally, continuous government initiatives for spreading awareness about blood pressure disorders among the citizens is another major factor which is projected to bolster the market growth. Also, new product developments by the key market players is further expected to boost the demand through FY2026.

The India telmisartan market is segmented based on indication, composition, form, route of administration, source, distribution channel, end user, company, and region. Based on composition, the market can be segmented into single and combinational. The combinational segment is expected to register highest CAGR in the market over the next 5 years which is accredited to increased efficacy and reduced side effects of combinational drugs. Along with this, it further aids in reducing the development of multiple drug resistance by the bacteria, which is further boosting the segmental growth in near future.

The major players operating in the India telmisartan market are Astellas Pharma India Pvt. Ltd., Boehringer Ingelheim India Pvt. Ltd., Novartis India Ltd., Venus Remedies Ltd., Candomed Pharmaceuticals India Pvt. Ltd, Torrent Pharmaceuticals Ltd., Cipla Limited (Exelan Pharmaceuticals), Lupin Laboratories Ltd., Mylan Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Astellas Pharma India Pvt. Ltd., and others. Major companies are developing advanced technologies, receiving approvals from regulatory bodies, and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new product developments.

Years considered for this report:

Historical Years: FY2016-FY2019

Base Year: FY2020

Estimated Year: FY2021

Forecast Period: FY2022–FY2026

Objective of the Study:

  • To analyze and estimate the market size of India telmisartan market from FY2016 to FY2019.
  • To estimate and forecast the market size of India telmisartan market from FY2020 to FY2026 and growth rate until FY2026.
  • To classify and forecast India telmisartan market based on indication, composition, form, route of administration, source, distribution channel, end user, company, and regional distribution.
  • To identify dominant region or segment in the India telmisartan market.
  • To identify drivers and challenges for India telmisartan market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India telmisartan market.
  • To identify and analyze the profile of leading players operating in India telmisartan market.
  • To identify key sustainable strategies adopted by market players in India telmisartan market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of India Telmisartan market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Telmisartan manufacturers/ suppliers/ distributors
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to telmisartan

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India telmisartan market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India Telmisartan Market, By Indication:
    • Hypertension
    • Cardiac Arrest
    • Stroke
    • Others
  • India Telmisartan Market, By Composition:
    • Single
    • Combinational
  • India Telmisartan Market, By Form:
    • Tablet
    • Capsule
    • Injection
    • Others
  • India Telmisartan Market, By Route of Administration:
    • Oral
    • Intravenous
  • India Telmisartan Market, By Source:
    • In-house
    • Contract Manufacturing Organizations
  • India Telmisartan Market, By Distribution Channel:
    • Online
    • Offline
  • India Telmisartan Market, By End User:
    • Adult
    • Pediatric
  • India Telmisartan Market, By Region:
    • North
    • South
    • East
    • West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India telmisartan market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
India telmisartan market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on India Telmisartan Market

4.    Executive Summary

5.    Manufacturing Telmisartan

5.1.  Raw Material

5.2.  Machinery

5.3.  Manufacturing Methods

5.4.  Contact Details of Machinery & Raw Material Suppliers

6.    Pharmacodynamic Overview of Telmisartan

6.1.  Mechanism of Action

6.2.  Absorption

6.3.  Volume of Distribution

6.4.  Protein Binding

6.5.  Metabolism

6.6.  Route of Elimination

6.7.  Half-Life

6.8.  Clearance

6.9.  Toxicity

7.    India Telmisartan Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Indication (Hypertension, Cardiac Arrest, Stroke, Others)

7.2.2.     By Composition (Single, Combinational)

7.2.3.     By Form (Tablet, Capsule, Injection, Others)

7.2.4.     By Route of Administration (Oral v/s Intravenous)

7.2.5.     By Source (In-house v/s Contract Manufacturing Organizations)

7.2.6.     By Distribution Channel (Online v/s Offline)

7.2.7.     By End User (Adult v/s Paediatric)

7.2.8.     By Region (North, East, South, West)

7.2.9.     By Company

7.3.  Product Market Map

8.    Market Dynamics

8.1.  Drivers/Opportunities

8.2.  Challenges/Restraints

9.    Market Trends & Developments

10.  Policy & Regulatory Landscape

10.1.              Custom Duty & Taxes

10.2.              Government Subsidy & Benefits

10.3.              Relevant Policies & Regulations (GMP, USFDA, WHO Certifications)

11.  Import & Export Analysis

12.  Pricing Analysis

13.  India Economic Profile

14.  Competitive Landscape

14.1.              Company Profiles

14.1.1.  Astellas Pharma India Pvt. Ltd.      Company Brief      Production Plants & Capacity (If Available)      Financials (If Available)      Captive Consumption Vs Merchant Sale      Current & Future Plans

14.1.2.  Boehringer Ingelheim India Pvt. Ltd.

14.1.3.  Novartis India Ltd.

14.1.4.  Venus Remedies Ltd.

14.1.5.  Candomed Pharmaceuticals India Pvt. Ltd

14.1.6.  Torrent Pharmaceuticals Ltd.

14.1.7.  Cipla Limited (Exelan Pharmaceuticals)

14.1.8.  Lupin Laboratories Ltd.

14.1.9.  Mylan Laboratories Ltd.

14.1.10.                Glenmark Pharmaceuticals Ltd.

15.  Strategic Recommendations

About Us & Disclaimer

Figures and Tables

Frequently asked questions